In the ROS1 mutation group, 16 patients (62.5%) developed tumor metastasis, and lung metastasis (5 cases, 31.3%, P = 0.045) and pleural metastasis (6 cases, 37.5%, P = 0.044) often occurred. The gene discussed is ROS1; the disease is neoplasm.